NO329518B1 - Reaktant og fremgangsmate for identifisering og telling av biologiske celler - Google Patents
Reaktant og fremgangsmate for identifisering og telling av biologiske celler Download PDFInfo
- Publication number
- NO329518B1 NO329518B1 NO20020866A NO20020866A NO329518B1 NO 329518 B1 NO329518 B1 NO 329518B1 NO 20020866 A NO20020866 A NO 20020866A NO 20020866 A NO20020866 A NO 20020866A NO 329518 B1 NO329518 B1 NO 329518B1
- Authority
- NO
- Norway
- Prior art keywords
- cells
- sample
- reagent according
- reagent
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000000376 reactant Substances 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 37
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 238000000684 flow cytometry Methods 0.000 claims abstract description 10
- 239000003599 detergent Substances 0.000 claims abstract description 9
- 230000003834 intracellular effect Effects 0.000 claims abstract description 9
- 230000002934 lysing effect Effects 0.000 claims abstract description 8
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 5
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 5
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 61
- 239000000523 sample Substances 0.000 claims description 31
- 239000000975 dye Substances 0.000 claims description 20
- 210000003743 erythrocyte Anatomy 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 12
- 238000010186 staining Methods 0.000 claims description 11
- 238000005259 measurement Methods 0.000 claims description 9
- 230000009089 cytolysis Effects 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 230000035515 penetration Effects 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 6
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims description 5
- -1 amine acetates Chemical class 0.000 claims description 5
- 230000002159 abnormal effect Effects 0.000 claims description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000002555 ionophore Substances 0.000 claims description 3
- 230000000236 ionophoric effect Effects 0.000 claims description 3
- 229920002477 rna polymer Polymers 0.000 claims description 3
- PXGXZGVGEDLSMW-UHFFFAOYSA-M (2e)-3-methyl-2-[(e)-3-(3-methyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole;iodide Chemical compound [I-].O1C2=CC=CC=C2[N+](C)=C1/C=C/C=C1/N(C)C2=CC=CC=C2O1 PXGXZGVGEDLSMW-UHFFFAOYSA-M 0.000 claims description 2
- GOWKLUFPXMGCIW-UHFFFAOYSA-N 1,3-benzoxazol-3-ium;iodide Chemical compound [I-].C1=CC=C2OC=[NH+]C2=C1 GOWKLUFPXMGCIW-UHFFFAOYSA-N 0.000 claims description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 claims description 2
- YTMLLNPQZXFMLZ-UHFFFAOYSA-N 2-(4-aminophenyl)-1H-indol-6-amine dihydrochloride Chemical compound Cl.Cl.C1=CC(N)=CC=C1C1=CC2=CC=C(N)C=C2N1 YTMLLNPQZXFMLZ-UHFFFAOYSA-N 0.000 claims description 2
- FKJVYOFPTRGCSP-UHFFFAOYSA-N 2-[3-aminopropyl(2-hydroxyethyl)amino]ethanol Chemical class NCCCN(CCO)CCO FKJVYOFPTRGCSP-UHFFFAOYSA-N 0.000 claims description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 2
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims description 2
- 108700012813 7-aminoactinomycin D Proteins 0.000 claims description 2
- 108010092160 Dactinomycin Proteins 0.000 claims description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 2
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 claims description 2
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 2
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 claims description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims description 2
- 150000001299 aldehydes Chemical class 0.000 claims description 2
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 claims description 2
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 claims description 2
- 239000013060 biological fluid Substances 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims description 2
- 229960000640 dactinomycin Drugs 0.000 claims description 2
- 150000004985 diamines Chemical class 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims description 2
- 229960005542 ethidium bromide Drugs 0.000 claims description 2
- UMSGVWVBUHUHEH-UHFFFAOYSA-M ethyl(trimethyl)azanium;bromide Chemical compound [Br-].CC[N+](C)(C)C UMSGVWVBUHUHEH-UHFFFAOYSA-M 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 229930182470 glycoside Natural products 0.000 claims description 2
- 150000003840 hydrochlorides Chemical class 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000003068 molecular probe Substances 0.000 claims description 2
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical class CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 claims description 2
- 230000001537 neural effect Effects 0.000 claims description 2
- 229920002866 paraformaldehyde Polymers 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920000151 polyglycol Polymers 0.000 claims description 2
- 239000010695 polyglycol Substances 0.000 claims description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- RAUSCQQFTBHLNM-UHFFFAOYSA-N quinolin-1-ium diiodide Chemical compound [I-].[I-].[NH+]1=CC=CC2=CC=CC=C12.[NH+]1=CC=CC2=CC=CC=C12 RAUSCQQFTBHLNM-UHFFFAOYSA-N 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- 235000017709 saponins Nutrition 0.000 claims description 2
- 150000003871 sulfonates Chemical class 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 claims description 2
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 2
- 239000012472 biological sample Substances 0.000 description 4
- 210000000601 blood cell Anatomy 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003924 normoblast Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- DOETVZCFKJCYJV-UHFFFAOYSA-N 6-(4,5-dihydro-1h-imidazol-2-yl)-2-[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]-1h-indole Chemical compound N1CCN=C1C1=CC=C(C=2NC3=CC(=CC=C3C=2)C=2NCCN=2)C=C1 DOETVZCFKJCYJV-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 101100286286 Dictyostelium discoideum ipi gene Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108010067973 Valinomycin Proteins 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 210000003969 blast cell Anatomy 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2525—Stabilizing or preserving
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Ecology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0102489A FR2821428B1 (fr) | 2001-02-23 | 2001-02-23 | Reactif et procede pour l'identification et le comptage de cellules biologiques |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20020866D0 NO20020866D0 (no) | 2002-02-22 |
| NO20020866L NO20020866L (no) | 2002-08-26 |
| NO329518B1 true NO329518B1 (no) | 2010-11-01 |
Family
ID=8860367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20020866A NO329518B1 (no) | 2001-02-23 | 2002-02-22 | Reaktant og fremgangsmate for identifisering og telling av biologiske celler |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20020182623A1 (sv) |
| EP (1) | EP1239283B1 (sv) |
| JP (2) | JP2002277460A (sv) |
| KR (1) | KR20020069177A (sv) |
| CN (1) | CN1220057C (sv) |
| AT (1) | ATE490460T1 (sv) |
| AU (1) | AU784651B2 (sv) |
| BR (1) | BRPI0200585B8 (sv) |
| CA (1) | CA2372608A1 (sv) |
| DE (1) | DE60238455D1 (sv) |
| ES (1) | ES2357524T3 (sv) |
| FI (1) | FI120895B (sv) |
| FR (1) | FR2821428B1 (sv) |
| HU (1) | HU227098B1 (sv) |
| NO (1) | NO329518B1 (sv) |
| ZA (1) | ZA200201300B (sv) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7745219B2 (en) * | 2003-07-21 | 2010-06-29 | Siemens Healthcare Diagnostics Inc. | Reagent composition for the analysis of residual white blood cells in leuko-reduced blood banking products |
| JP4911601B2 (ja) * | 2004-02-10 | 2012-04-04 | ベックマン コールター， インコーポレイテッド | 有核赤血球細胞の計測方法 |
| RU2007101509A (ru) | 2004-06-17 | 2008-07-27 | Уайт (Us) | Способ получения антагонистов рецепторов гормона, высвобождающего гонадотропин |
| MXPA06014798A (es) | 2004-06-17 | 2007-06-22 | Wyeth Corp | Antagonistas del receptor de hormona para liberar gonadotropina. |
| FR2873813B1 (fr) * | 2004-07-30 | 2006-11-17 | Abx Sa | Procede et dispositif de caracterisation des composants cellulaires d'un liquide biologique |
| CA2587853A1 (en) * | 2004-11-23 | 2006-06-01 | Wyeth | Gonadotropin releasing hormone receptor antagonists |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US20060189619A1 (en) * | 2005-02-24 | 2006-08-24 | Wyeth | 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds |
| FR2883972B1 (fr) * | 2005-03-31 | 2007-11-16 | C2 Diagnostics Sa | Procede pour l'analyse d'un echantillon de sang et appareil et reactif pour sa mise en oeuvre |
| JP2008538611A (ja) * | 2005-04-21 | 2008-10-30 | セレラス ダイアグノスティクス， インコーポレイテッド | 自動高速免疫組織化学のための平行処理の流体方法および装置 |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| JP4976038B2 (ja) | 2006-03-29 | 2012-07-18 | シスメックス株式会社 | 血液学的試料の測定方法 |
| CN1945326A (zh) * | 2006-10-13 | 2007-04-11 | 江西特康科技有限公司 | 基于视觉形态的五分类全血细胞分析方法 |
| CN101349644B (zh) | 2007-07-20 | 2012-06-27 | 深圳迈瑞生物医疗电子股份有限公司 | 一种白细胞分类试剂和其使用方法 |
| US8102161B2 (en) * | 2007-09-25 | 2012-01-24 | Tdk Corporation | Stable output in a switching power supply by smoothing the output of the secondary coil |
| CN101475754A (zh) | 2008-01-04 | 2009-07-08 | 深圳迈瑞生物医疗电子股份有限公司 | 不对称菁类荧光染料,组合物及在生物样品染色中的用途 |
| US9017610B2 (en) | 2008-04-25 | 2015-04-28 | Roche Diagnostics Hematology, Inc. | Method of determining a complete blood count and a white blood cell differential count |
| US9602777B2 (en) | 2008-04-25 | 2017-03-21 | Roche Diagnostics Hematology, Inc. | Systems and methods for analyzing body fluids |
| CN101602762B (zh) | 2008-06-10 | 2013-10-16 | 深圳迈瑞生物医疗电子股份有限公司 | 不对称菁类化合物、其制备方法及应用 |
| FR2935802B1 (fr) * | 2008-09-05 | 2012-12-28 | Horiba Abx Sas | Procede et dispositif de classification, de visualisation et d'exploration de donnees biologiques |
| CN101726579B (zh) | 2008-10-17 | 2014-06-18 | 深圳迈瑞生物医疗电子股份有限公司 | 血液检测试剂和方法 |
| CN101750274B (zh) | 2008-12-17 | 2014-06-25 | 深圳迈瑞生物医疗电子股份有限公司 | 白细胞分类计数试剂、试剂盒以及白细胞分类计数的方法 |
| CN101988082B (zh) | 2009-07-31 | 2015-04-08 | 深圳迈瑞生物医疗电子股份有限公司 | 白细胞分类计数试剂、试剂盒及其制备方法和白细胞分类计数的方法 |
| FR2956207B1 (fr) | 2010-02-10 | 2012-05-04 | Horiba Abx Sas | Dispositif et procede de mesures multiparametriques de microparticules dans un fluide |
| US9111343B2 (en) | 2011-01-18 | 2015-08-18 | Roche Diagnostics Hematology, Inc. | Microscope slide coordinate system registration |
| FR2971337B1 (fr) | 2011-02-04 | 2013-03-01 | Horiba Abx Sas | Dispositif et procede de mesures multiparametriques de microparticules dans un fluide |
| ES2755785T3 (es) * | 2011-05-04 | 2020-04-23 | Abbott Lab | Método de análisis de basófilos |
| CN103987834B (zh) | 2011-05-04 | 2017-03-29 | 雅培制药有限公司 | 白细胞分析系统和方法 |
| US9103759B2 (en) | 2011-05-04 | 2015-08-11 | Abbott Laboratories | Nucleated red blood cell analysis system and method |
| JP5416232B2 (ja) * | 2012-01-23 | 2014-02-12 | シスメックス株式会社 | 血液学的試料の測定装置 |
| EP2847589A1 (en) | 2012-05-09 | 2015-03-18 | Advanced Animal Diagnostics, Inc. | Rapid detection of analytes in liquid samples |
| FR2994740B1 (fr) | 2012-08-21 | 2015-03-27 | Horiba Abx Sas | Procede de compensation du vieillissement d'un reactif lors de mesures de fluorescence sur des particules, et dispositif d'analyse biologique mettant en œuvre le procede. |
| CN109142195B (zh) | 2013-03-15 | 2021-10-01 | 艾瑞思国际股份有限公司 | 用于体液样品中的粒子分析的自聚焦系统和方法 |
| US9316635B2 (en) | 2013-03-15 | 2016-04-19 | Iris International, Inc. | Sheath fluid systems and methods for particle analysis in blood samples |
| EP2998738B1 (en) | 2013-05-13 | 2020-02-12 | Konica Minolta, Inc. | Cell-staining method and specimen collection tube for use in method |
| GB201415367D0 (en) * | 2014-08-29 | 2014-10-15 | Iles Raymond K And Docherty Suzanne M E And Abban Thomas And Naase Mahmoud And Iles Jason K | Methods for detecting abnormalities in haemoglobin |
| CN105759029A (zh) * | 2016-02-24 | 2016-07-13 | 天津市宝坻区人民医院 | 麻疹病毒检测试剂盒及使用方法 |
| EP4252629A3 (en) | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Gastrointestinal tract detection methods, devices and systems |
| JP2021501321A (ja) * | 2017-10-26 | 2021-01-14 | エッセンリックス コーポレーション | 組織および細胞染色のためのデバイスおよび方法 |
| CN111088313B (zh) * | 2019-12-16 | 2024-05-14 | 中国水产科学研究院珠江水产研究所 | 一种用于快速固定嗜热四膜虫细胞计数的试剂及其计数方法 |
| JP7293269B2 (ja) * | 2021-02-22 | 2023-06-19 | シスメックス株式会社 | 溶血試薬、試薬キットおよび白血球の分類方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751179A (en) * | 1984-05-31 | 1988-06-14 | Coulter Electronics, Inc. | Method and reagents for differential determination of four populations of leukocytes in blood |
| DE3814811A1 (de) * | 1988-05-02 | 1989-11-16 | Merck Patent Gmbh | Verfahren und mittel zur differenzierung und bestimmung von leukozyten |
| FR2654744B1 (fr) * | 1989-11-20 | 1992-03-13 | Abx Sa | Reactif et methode d'utilisation de celui-ci pour la determination automatique en cytometrie de flux d'au moins une sous-population leucocytaire a partir du sang total. |
| EP0598663B1 (en) * | 1992-11-19 | 2000-02-02 | Sysmex Corporation | A pretreatment method for blood analysis |
| ES2284160T3 (es) * | 1993-02-25 | 2007-11-01 | Abbott Laboratories | Sistema reactivo multiuso capaz de lisar rapidamente muestras de sangre completa. |
| US5656499A (en) * | 1994-08-01 | 1997-08-12 | Abbott Laboratories | Method for performing automated hematology and cytometry analysis |
| FR2759166B1 (fr) * | 1997-01-31 | 1999-04-23 | Abx Sa | Reactif de coloration pour la determination de cellules sanguines |
| US6271035B1 (en) * | 1998-10-20 | 2001-08-07 | Coulter International Corp. | Methods and compositions for rapid staining of nucleic acids in whole cells |
| US6562563B1 (en) * | 1999-11-03 | 2003-05-13 | Mitokor | Compositions and mehtods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
-
2001
- 2001-02-23 FR FR0102489A patent/FR2821428B1/fr not_active Expired - Lifetime
-
2002
- 2002-02-15 ZA ZA200201300A patent/ZA200201300B/xx unknown
- 2002-02-18 DE DE60238455T patent/DE60238455D1/de not_active Expired - Lifetime
- 2002-02-18 EP EP02290387A patent/EP1239283B1/fr not_active Expired - Lifetime
- 2002-02-18 ES ES02290387T patent/ES2357524T3/es not_active Expired - Lifetime
- 2002-02-18 AU AU15667/02A patent/AU784651B2/en not_active Ceased
- 2002-02-18 AT AT02290387T patent/ATE490460T1/de not_active IP Right Cessation
- 2002-02-19 HU HU0200626A patent/HU227098B1/hu unknown
- 2002-02-19 CA CA002372608A patent/CA2372608A1/fr not_active Abandoned
- 2002-02-21 BR BRPI0200585A patent/BRPI0200585B8/pt not_active IP Right Cessation
- 2002-02-22 CN CNB021183619A patent/CN1220057C/zh not_active Expired - Lifetime
- 2002-02-22 NO NO20020866A patent/NO329518B1/no not_active IP Right Cessation
- 2002-02-22 FI FI20020355A patent/FI120895B/sv not_active IP Right Cessation
- 2002-02-22 JP JP2002046658A patent/JP2002277460A/ja active Pending
- 2002-02-23 KR KR1020020009730A patent/KR20020069177A/ko not_active Application Discontinuation
- 2002-02-25 US US10/081,118 patent/US20020182623A1/en not_active Abandoned
-
2006
- 2006-12-29 US US11/647,268 patent/US7638290B2/en not_active Expired - Lifetime
-
2008
- 2008-06-16 JP JP2008157006A patent/JP2008256713A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HU227098B1 (en) | 2010-07-28 |
| AU784651B2 (en) | 2006-05-18 |
| FR2821428A1 (fr) | 2002-08-30 |
| FI120895B (sv) | 2010-04-15 |
| FI20020355A0 (sv) | 2002-02-22 |
| JP2008256713A (ja) | 2008-10-23 |
| EP1239283B1 (fr) | 2010-12-01 |
| NO20020866L (no) | 2002-08-26 |
| BRPI0200585B1 (pt) | 2016-05-17 |
| HUP0200626A2 (hu) | 2003-06-28 |
| FR2821428B1 (fr) | 2004-08-06 |
| CA2372608A1 (fr) | 2002-08-23 |
| FI20020355A (sv) | 2002-08-24 |
| ATE490460T1 (de) | 2010-12-15 |
| US20070111276A1 (en) | 2007-05-17 |
| DE60238455D1 (de) | 2011-01-13 |
| EP1239283A1 (fr) | 2002-09-11 |
| BRPI0200585B8 (pt) | 2021-07-27 |
| AU1566702A (en) | 2002-08-29 |
| NO20020866D0 (no) | 2002-02-22 |
| CN1220057C (zh) | 2005-09-21 |
| ES2357524T3 (es) | 2011-04-27 |
| CN1385701A (zh) | 2002-12-18 |
| HU0200626D0 (en) | 2002-04-29 |
| KR20020069177A (ko) | 2002-08-29 |
| US7638290B2 (en) | 2009-12-29 |
| ZA200201300B (en) | 2002-08-27 |
| US20020182623A1 (en) | 2002-12-05 |
| JP2002277460A (ja) | 2002-09-25 |
| BR0200585A (pt) | 2002-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO329518B1 (no) | Reaktant og fremgangsmate for identifisering og telling av biologiske celler | |
| US6114173A (en) | Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood | |
| EP1004880B1 (en) | Erythroblast diagnostic flow-cytometry method and reagents | |
| US7625712B2 (en) | Method for a fully automated monoclonal antibody-based extended differential | |
| DE69534429T2 (de) | Verfahren und vorrichtung zur durchführung automatischer analysen | |
| US5434081A (en) | Method of classifying leukocytes by flow cytometry | |
| US7674598B2 (en) | Method for a fully automated monoclonal antibody-based extended differential | |
| CN101086473B (zh) | 试样分析用试剂、试样分析用试剂盒及试样分析方法 | |
| US20040185447A1 (en) | Dye compositions which provide enhanced differential fluorescence and light scatter characteristics | |
| JPH01199161A (ja) | 白血球を定量且つ識別する方法 | |
| JPH03266999A (ja) | 全血からの少なくとも一つの白血球のサブ‐ポピュレーションの自動フローサイトメトリー測定用の試薬及び該試薬を用いた測定方法 | |
| CN101097181A (zh) | 试样分析用试剂、试样分析用试剂盒及试样分析方法 | |
| US20040241770A1 (en) | Process for discriminating and counting erythroblasts | |
| JP4087560B2 (ja) | 赤芽球の識別方法 | |
| JP2009080122A (ja) | 赤芽球の分類計数方法 | |
| JPH07113632B2 (ja) | 白血球分析方法 | |
| US5045474A (en) | Semi-automatic process for white cell differential count | |
| Sakata | Reagent characteristics in the XE-2100 NRBC channel | |
| Kelliher et al. | Novel use of the BD FACS™ SPA to automate custom monoclonal antibody panel preparations for immunophenotyping |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |